NotizieBenzingaInvivyd And SPEAR Study Group Initiate FLINTLOCK Phase 2 Trial Evaluating Safety, Tolerability, Pharmacokinetics, And Clinical Efficacy Of High-Dose Monoclonal Antibody VYD2311 In Individuals With Long COVID Or Post-Vaccination Syndrome Invivyd And SPEAR Study Group Initiate FLINTLOCK Phase 2 Trial Evaluating Safety, Tolerability, Pharmacokinetics, And Clinical Efficacy Of High-Dose Monoclonal Antibody VYD2311 In Individuals With Long COVID Or Post-Vaccination Syndrome Benzinga 2026.10.14 11:05 (GMT+0) Apri Benzinga Altre notizie Citizens conferma il rating sul titolo Ideaya Biosciences prima dell’ESMO Perché il titolo OHB sta salendo oggi? Citizens conferma il rating su Celcuity in vista dei dati ESMO Perché il titolo Serica Energy sta scendendo oggi? Citizens alza il target su Exelixis a $65 dopo i dati ESMO UBS promuove JetBlue a Neutral per equilibrio rischio-rendimento
